Akerna (KERN) Misses Q1 EPS by 52c
Get Alerts KERN Hot Sheet
Join SI Premium – FREE
Akerna (NASDAQ: KERN) reported Q1 EPS of ($0.69), $0.52 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $6.95 million versus the consensus estimate of $6.2 million.
For earnings history and earnings-related data on Akerna (KERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
- LATAM Airlines (LTM) Misses Q3 EPS by 135c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share